Alliance Wealth Advisors LLC UT lowered its stake in Abbott Laboratories (NYSE: ABT) by 30.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,225 shares of the healthcare product maker's stock after selling 8,086 shares during the quarter. Alliance

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE: ABT) at the special meeting of stockholders held earlier today. At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Scie.

ABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.

Abbott edges out Boston Scientific in the MedTech faceoff, with valuation appeal, strong CGM momentum and strategic deals boosting its investment case.

Elefante Mark B boosted its position in shares of Abbott Laboratories (NYSE: ABT) by 12.7% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 43,648 shares of the healthcare product maker's stock after purchasing an additional 4,910 shares during the quarter. Abbott Laboratories

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

LISTING LINK: https://www.premiersothebysrealty.com/single-family/mfr/a4681242/6610-gulf-of-mexico-drive-longboat-key-fl-34228 DROPBOX: https://tours.coastalhomephotography.net/public/vtour/display/2359971?idx=1#!/nav/gallery PHOTO CREDIT: Coastal Home Photography LONGBOAT KEY, Fla.

Fifth Third Bancorp lowered its stake in shares of Abbott Laboratories (NYSE: ABT) by 0.8% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,315,759 shares of the healthcare product maker's stock after selling 10,616 shares during the quarter. Fifth Third Bancorp

In the fourth quarter of 2025, the Baron Discovery Fund returned 0.19% (Institutional Shares), trailing the Russell 2000 Growth Index by 1.03%. In these periods, low quality (high debt and poor profitability) and short-term price momentum-oriented stocks outperformed. Exact Sciences Corporation received a buyout offer in the fourth quarter by Abbott Laboratories (ABT) for a price of $105 in cash.

Cidel Asset Management Inc. increased its position in shares of Abbott Laboratories (NYSE: ABT) by 2.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 335,841 shares of the healthcare product maker's stock after buying an additional 6,660 shares during